
sean wharton
@seanwharton
Physician, general internal medicine, UofT graduate from Medicine and PharmD, McMaster residency. obesity medicine clinician and researcher
ID: 221186830
http://Whartonmedicalclinc.com 29-11-2010 23:59:03
522 Tweet
2,2K Followers
174 Following


Delve into the multifaceted world of obesity with sean wharton. Listen as we unravel the complexities of genetics, medication, and stigma surrounding this critical health issue. #DitchTheLabCoat #ObesityAwareness #HealthTalk episodes.fm/1730562799

Meet our very own sean wharton. Excited to have him share his #patientcenteredapproach and positive insights at our upcoming #YourHealthMatters Summit 2024. To Join us Register here: obesity-matters.com/events/your-he…

Now, medical students will HAVE to learn about anti-Black racism & Black health! MedCouncilCan just released Black Health learning objectives! Proud to have co-led this with DrDryden & Dr. Barb Black Health Education Collaborative ! Temerty Medicine U of T Public Health 🤓


Did you know? Despite common assumptions, only 25% of people with obesity develop type 2 diabetes. sean wharton delves into the critical role of genetics in this complex relationship, shedding light on the interplay between our DNA and lifestyle factors.episodes.fm/1730562799






Is Weight Loss–Induced Muscle Mass Loss Clinically Relevant? | Lifestyle Behaviors | JAMA | JAMA Network Amazing@summary of what we know to date. Excellent Caterina Conte jamanetwork.com/journals/jama/…

Low calorie diets result in mitochondrial dysfunction and bariatric surgery maintains the function. Is this rhe reason for the weight regain with diets. Great study Kirsi Pietiläinen . We need information on resistance training and pharmacotherapy. pubmed.ncbi.nlm.nih.gov/25972572/


Who is at higher risk of aspiration pneumonia with respect to GLP1 / GIP receptor agonist? DrSuePedersen #ADASciSessions


Clinical strategies for mitigating adverse events with GLP-1 medicines Beverly G. Tchang, MD #ADA2024 pubmed.ncbi.nlm.nih.gov/34775881/




Experts reveal a new weight loss drug achieving 22% average loss, targeting harmful visceral fat. A major step forward in managing obesity as a chronic disease! Obesity Canada Ian Patton, PHD sean wharton #ObesityMatters #HealthBreakthroughs ow.ly/k3JG50Uz1BO

